drugset / Trial / NCT04556370

Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia.

NCT04556370 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to investigate the suitable infusion dose of norepinephrine for prophylaxis against postspinal anesthesia hypotension in parturients with preeclampsia undergoing cesarean section.

Timeline

Start
2021-11-16
Primary completion
2023-06-06
Completion
2023-06-06

Outcome

Met primary endpoint

paper incidence of maternal hypotension was reduced with different prophylactic infusion rates of norepinephrine (26.7%, 15.6%, and 6.7%) compared with normal saline (37.8%) PMID 38869701 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Norepinephrine Other / unclassified 0.025 ug/kg —
Subject Norepinephrine Other / unclassified 0.05 ug/kg —
Subject Norepinephrine Other / unclassified 0.075 ug/kg —

Indications

No indication recorded.